Cetaben
CAS No. 55986-43-1
Cetaben ( —— )
产品货号. M26644 CAS No. 55986-43-1
Cetaben 是一种不依赖于 PPARα 的过氧化物酶体增殖剂。 Cetaben是一种非纤维化降脂化合物,可有效降低胆固醇和甘油三酯浓度。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥883 | 有现货 |
|
| 10MG | ¥1531 | 有现货 |
|
| 25MG | ¥2584 | 有现货 |
|
| 50MG | ¥3848 | 有现货 |
|
| 100MG | ¥5524 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Cetaben
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Cetaben 是一种不依赖于 PPARα 的过氧化物酶体增殖剂。 Cetaben是一种非纤维化降脂化合物,可有效降低胆固醇和甘油三酯浓度。
-
产品描述Cetaben is a PPARα-independent peroxisome proliferator. Cetaben is a non-fibrotic lipid-lowering drug that effectively reduces cholesterol and triglyceride concentrations.(In Vitro):The administration of 10 μM Cetaben for 24 hours induces severe micromorphological and ultrastructural changes in HepG2 and MH1C1 cells. After the administration of 10 μM Cetaben for 24 hours, cells were characterized by a striking heterogeneity of the peroxisomal population with the occurrence of dumbbell-shaped and cup-shaped peroxisomal profiles in MH1C1cells. After administration with 100 μM cetaben, cells contained several Golgi regions, most of them disintegrated into vesicles.(In Vivo):Administration of 50-100 mg/kg Cetaben for over 10 days shows an obvious rise in the activities of peroxisomal enzymes in both the liver and kidney. However, the maximal effect is observed at 250 mg/kg.
-
体外实验Cetaben (10 μM; 24 hours) induces severe micromorphological and ultrastructural changes in HepG2 and MH1C1 cells. After treatment with 100 μM cetaben, cells contained several Golgi regions, most of them disintegrated into vesicles. Cetaben-treated (10 μM; 24 hours) cells were characterized by a striking heterogeneity of the peroxisomal population with the occurrence of dumbbell-shaped and cup-shaped peroxisomal profiles in MH1C1cells.
-
体内实验Cetaben reveales a significant rise in the activities of peroxisomal enzymes in both the liver and kidney at doses of 50-100 mg/kg body over 10 days, but the maximal effect is observed at 250 mg/kg. Animal Model:Male Wistar rats Dosage:10,25,50,100,250 and 500 mg/kg Administration:Gavage; 10 dayResult:Revealed a significant rise in the activities of peroxisomal enzymes in both the liver and kidney at doses of 50-100 mg/kg body over 10 days, but the maximal effect was observed at 250 mg/kg.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Endogenous Metabolite| Influenza A
-
研究领域——
-
适应症——
化学信息
-
CAS Number55986-43-1
-
分子量361.57
-
分子式C23H39NO2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 25 mg/mL (69.14 mM)
-
SMILESCCCCCCCCCCCCCCCCNc1ccc(cc1)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Takahashi T, et al. N-glycolylneuraminic acid on human epithelial cells prevents entry of influenza A viruses that possess N-glycolylneuraminic acid binding ability. J Virol. 2014 Aug;88(15):8445-56.
产品手册
关联产品
-
Phthalic acid
邻苯二甲酸是一种芳香族二羧酸。它是一种人类外源代谢物。
-
N-Methylcorydalmine
N-Methylcorydalmine may exhibit significant anti-hypoxia activity.
-
Copper(II) D-glucona...
D-葡萄糖酸铜(II)粉末与硅结合用于制造碳包覆的Si-Cu3Si复合材料作为锂离子电池的负极材料。
021-51111890
购物车()
sales@molnova.cn

